fyi...
Announcement: Clinical Trial for Fibromyalgia and ME/CFS Patients
June 2013
Please see below 2 articles that discuss this protocol (or just google Pridgen + Fibromyalgia)
http://www.prohealth.com/library/showarticle.cfm?libid=17194
http://www.tuscaloosanews.com/article/20120909/NEWS/120909792
This Phase II clinical trial known by the acronym "FAST" (Fibromyalgia Antiviral Suppression Therapy) is for Fibromyalgia patients, and some qualifying ME/CFS patients. The study uses a combination of a NSAID medication and an antiviral medication (there are 3 types of each that work) to suppress herpes simplex virus (HSV-1), the proposed cause of Fibromyalgia and perhaps ME/CFS. Patients interested in getting in the clinical trial should have their doctors contact Dr. Pridgen directly at
tsasurgery(at)gmail.com Here is a list of the 12 sites conducting the study.
IMC research sites for PRID-1 Study (FAST-fibromyalgia antiviral suppression therapy)
1) Aftine MD - Medford, OR
2) Bateman MD - Salt Lake City, UT
3) Dikranian MD - San Diego, CA
4) Garcia MD - Sacramento, CA
5) Graves MD - Evansville, IN
6) Lafata MD - Vista, CA
7) Lockwood MD - Lafayete, IN
8) Matthews MD - Jacksonville, FL
9) Prestegard MD - Ann Arbor, MI
10) Rubino MD - Raleigh, NC
11) Williams MD - Birmingham, AL
12) Huffman MD - Tampa, FL